Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics

Journal of Medical Virology

Volumn 86, Issue 5, 2014, Pages 729-736

  Lai, Alessia ^a   Bozzi, Giorgio ^a   Franzetti, Marco ^a   Binda, Francesca ^a   Simonetti, Francesco R ^a   Micheli, Valeria ^a   Meraviglia, Paola ^a   Corsi, Paola ^b   Bagnarelli, Patrizia ^c   De Luca, Andrea ^d   Ciccozzi, Massimo ^e   Zehender, Gianguglielmo ^a   Zazzi, Maurizio ^d   Balotta, Claudia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UOC Infectious Diseases Careggi   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e Italian Institute of Health   (Italy)

Author keywords

HIV 1 C subtype; Italian epidemiological networks; Phylogeographic analysis

Indexed keywords

CD4 ANTIGEN;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; EPIDEMIC; FEMALE; HETEROSEXUALITY; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN C); HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; ITALY; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MIDDLE AGED; PHYLOGENY; PHYLOGEOGRAPHY; SEX DIFFERENCE; SEXUAL INTERCOURSE; STRUCTURAL GENE; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

HIV-1 C SUBTYPE; ITALIAN EPIDEMIOLOGICAL NETWORKS; PHYLOGEOGRAPHIC ANALYSIS;

ADULT; ANIMALS; CLUSTER ANALYSIS; EPIDEMICS; FEMALE; GENOTYPE; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HOMOSEXUALITY; HUMANS; ITALY; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGEOGRAPHY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; SOUTH AMERICA;

EID: 84895930060     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23891     Document Type: Article

References (20)

1. Bello G, Zanotto PM, Iamarino A, Gräf T, Pinto AR, Couto-Fernandez JC, Morgado MG. 2012. Phylogeographic analysis of HIV-1 subtype C dissemination in Southern Brazil. PLoS ONE 7:e35649.
2. de Oliveira T, Pillay D, Gifford RJ, UK Collaborative Group on HIV Drug Resistance. 2010. The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS ONE 5:e9311.
3. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214.
4. Hughes GJ, Fearnhill E, Dunn D, Lycett SJ, Rambaut A, Leigh Brown AJ, UK HIV Drug Resistance Collaboration. 2009. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog 5:e1000590.
5. Hemelaar J, Gouws E, Ghys PD, Osmanov S. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13-W23.
6. Hemelaar J. 2013. Implications of HIV diversity for the HIV-1 pandemic. J Infect 66:391-400.
7. Kass RE, Raftery AE. 1995. Bayes factors. J. Am Stat Assoc 90:773-795.
8. Lai A, Riva C, Marconi A, Balestrieri M, Razzolini F, Meini G, Vicenti I, Rosi A, Saladini F, Caramma I, Franzetti M, Rossini V, Galli A, Galli M, Violin M, Zazzi M, Balotta C. 2010. Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades. HIV Med 11:593-602.
9. Monno L, Brindicci G, Lai A, Punzi G, Altamura M, Simonetti FR, Ladisa N, Saracino A, Balotta C, Angarano G. 2012. An outbreak of HIV-1 BC recombinants in Southern Italy. J Clin Virol 55:370-373.
10. Osmanov S, Pattou C, Walker N, Schwardländer B, Esparza J, WHO-UNAIDS Network for HIV Isolation and Characterization. 2002. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 29:184-190.
11. Peeters M, Sharp PM. 2000. Genetic diversity of HIV-1: The moving target. AIDS 14:S129-S140.
12. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, Damond F, Robertson DL, Simon F. 2009. A new human immunodeficiency virus derived from gorillas. Nat Med 15:871-872.
13. Slatikin M, Maddison WP. 1989. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 123:401-416.
14. Stürmer M, Stephan C, Gute P, Knecht G, Bickel M, Brodt HR, Doerr HW, Gürtler L, Lecocq P, van Houtte M. 2011. Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes. Antimicrob Agents Chemother 55:5362-5366.
15. TakebE Y, Kusagawa S, Motomura K. 2004. Molecular epidemiology of HIV: Tracking AIDS pandemic. Pediatr Int 46:236-244.
16. Tebit DM, Arts EJ. 2011. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 11:45-56.
17. Thomson MM, Pérez-Alvarez L, Nájera R. 2002. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2:461-471.
18. Véras NM, Gray RR, Brígido LF, Rodrigues R, Salemi M. 2011. High-resolution phylogenetics and phylogeography of human immunodeficiency virus type 1 subtype C epidemic in South America. J Gen Virol 92:1698-1709.
19. Vidal N, Mulanga C, Bazepeo SE, Mwamba JK, Tshimpaka J, Kashi M, Mama N, Valéa D, Delaporte E, Lepira F, Peeters M. 2006. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). AIDS Res Hum Retroviruses 22:202-206.
20. Zaccarelli M, Spizzichino L, Venezia S, Antinori A, Gattari P. 2004. Changes in regular condom use among immigrant transsexuals attending a counselling and testing reference site in central Rome: A 12 year study. Sex Transm Infect 80:541-545.